News

Alnylam Pharmaceuticals to Host Q4 2024 Financial Results Call

Alnylam Pharmaceuticals to Host Q4 2024 Financial Results Call

Alnylam Pharmaceuticals Plans Financial Results Webcast

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leader in RNA interference (RNAi) therapeutics, has announced its intention to report its financial outcomes for the fourth quarter and full year of 2024. The results will be disclosed on a Thursday morning before the U.S. financial markets commence operations on February 13, 2025.

Insights from the Upcoming Call

During the anticipated conference call, scheduled for 8:30 AM ET on the same day, management will share insightful updates regarding company operations. They will thoroughly discuss the financial results for both the fourth quarter and the entire year, alongside future projections. Investors can listen live to the conference via an audio webcast accessible in the Investors section of Alnylam's official website.

Discover Alnylam's Innovative Solutions

Since its establishment in 2002, Alnylam has pioneered the field of RNA interference, striving to create a transformative class of medicines aimed at addressing the unmet medical needs of individuals suffering from various diseases. This ground-breaking work is anchored in Nobel Prize-winning research, focusing on the development of RNAi therapeutics that have demonstrated clinical efficacy.

Current Product Portfolio and Pipeline

Alnylam's commercial offerings include therapies like ONPATTRO (patisiran), AMVUTTRA (vutrisiran), GIVLAARI (givosiran), OXLUMO (lumasiran), and Leqvio (inclisiran), the latter developed in partnership with Novartis. Its rich pipeline also boasts multiple investigational medicines, particularly those in advanced stages of development. Through its innovative strategies, Alnylam aims to deliver impactful therapies targeting both rare and more common illnesses.

Commitment to Innovation and Patient Care

Alnylam is executing its strategic initiative known as "Alnylam P5x25," designed to facilitate sustained innovation in medicine. This initiative not only emphasizes scientific research but also aims to promote exceptional financial outcomes. By prioritizing the needs of patients globally, Alnylam is dedicated to improving health outcomes and quality of life for individuals living with serious medical conditions.

Connecting with Alnylam Pharmaceuticals

Headquartered in Cambridge, MA, Alnylam continues to make strides in the biotech field by engaging effectively with its audience. To learn more about Alnylam's ongoing projects and the science behind its therapies, interested parties can explore their official website. Additionally, Alnylam maintains an active presence on various social media platforms, enabling direct communication and updates on their research and community initiatives.

Frequently Asked Questions

1. What financial results will Alnylam report?

Alnylam will report its fourth quarter and full year financial results for 2024 on February 13, 2025.

2. How can I listen to the conference call?

The conference call can be accessed via a live audio webcast available on Alnylam's official website.

3. What is RNAi therapeutics?

RNAi therapeutics are a new class of medicines that utilize the RNA interference mechanism to target and silence disease-causing genes.

4. What is Alnylam's mission?

Alnylam's mission is to transform the lives of patients with serious diseases through innovative RNAi-based therapies.

5. Where is Alnylam headquartered?

Alnylam Pharmaceuticals is headquartered in Cambridge, MA.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

FSBO.com Boosts Real Estate Game with New Apps

Updated Category News Views 62

FSBO.com Bets Big on Mobile With New App Launch FSBO.com has unleashed something that might just shake up how we think about buying and selling homes. They're not just rolling out apps—they're weaving another layer onto the fabric of real estate itself. While other players tossed their hats into the app game long ago, FSBO.com is kicking it up a notch with their new iOS...

Continue Reading
JobPlanner Advances Mobile Tech for Construction Crews

Updated Category News Views 54

JobPlanner's Attempt to Tackle a Labor Crunch Construction's been walking on the tightrope for a while now. With a workforce that's graying like a couple of old Neanderthals and fewer fresh faces showing up on site, contractors are sweating bullets. Today, in the thickets of Austin's business landscape, JobPlanner rolled out an expanded Mobile Field Management toolkit,...

Continue Reading
Understanding Hired & Non-Owned Auto Insurance Basics

Updated Category News Views 48

The Overlooked Gap in Auto Coverage Bet you didn't see this one coming: businesses often overestimate their auto insurance coverage, assuming their commercial policies cover all the bases. When employees drive personal vehicles for work purposes or when businesses borrow rides temporarily, these assumptions leave a gaping hole bigger than a sinkhole in a Florida street....

Continue Reading
Alscan Clinches Three PSA Awards, Sets Industry Standard

Updated Category News Views 154

Alscan's Triple Trophy Triumph with PSA Network in 2026 Talk about setting the bar high! Alscan snagged not one, not two, but three prestigious awards from the PSA Network—quite a haul for any outfit looking to make waves in the security systems game. The recognition showcases their prowess in custom security solutions, serving businesses and industries with vigilance...

Continue Reading
Xinjiang Women Embrace New Horizons in Tianshan Peaks

Updated Category News Views 89

Scaling New Heights in Xinjiang Up there on the Tianshan Mountains, looking past those towering cliffs, what catches the eye isn't just breathtaking views but rising opportunities. In the land of Xinjiang, far from the bustling metropolises, young women are finding platforms to not just exist but to thrive. City by city, the narrative is changing as these women carve...

Continue Reading
TalentNeuron and CodeSignal Team Up: Impact on Workforce

Updated Category News Views 64

Skills Intelligence Takes Center Stage There's a fresh breeze blowing through the workforce planning domain, thanks to the newly expanded partnership between TalentNeuron and CodeSignal. They've strapped together their expertise to craft what's now touted as the most comprehensive skills intelligence available to organizations. A claim big enough to make us stop,...

Continue Reading
FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 353

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
Photocure Navigates AssureMDx's Medicare Journey

Updated Category News Views 99

Aiming High with AssureMDx Photocure's got this bladder cancer test called AssureMDx that's at the center of its recent moves after acquiring Vesica Health a few months back. This isn't just any test; it's a urine-based, non-invasive way to snag an early look at bladder cancer. With the FDA's Breakthrough Device tag pinned on, they're not just dipping their toes in—this...

Continue Reading
Global Vineyards List: New Entrants & Rankings Unveiled

Updated Category News Views 93

Vineyards' Global Ranking Unveiled Wine enthusiasts and globetrotters have something to toast about this November. The 50 Best Vineyards just expanded its ranking to reveal the vineyards sitting in spots 51 through 100 for 2026. This list, spotlighting some of the globe's finest wine destinations, precedes the main awards ceremony set for November 18 in Santiago, Chile....

Continue Reading
Shark Thriller Upends Predator Preconceptions

Updated Category News Views 24

Not Another Jaws Knockoff: Embracing the Unexpected It’s about time that shark stories got more nuanced. “Return of the Mako” by William McKeever doesn't rehash the usual man-eating trope. Instead, it throws the usual assumptions out the window and gives us a fresh perspective. Sharks, infamous for inspiring fear and cunningly captured on the silver screen as apex...

Continue Reading

Top 5 Most Recently Viewed Articles

EU Races to Establish Joint Purchasing Platform for Minerals

Updated Category News Views 91

EU's Strategic Move to Create a Critical Minerals Platform The European Union is working towards establishing a joint purchasing mechanism aimed at acquiring critical minerals and energy resources. To realize this ambitious plan, the EU is evaluating eight bidders vying for the opportunity to develop this essential platform. Importance of Critical Minerals in the Green...

Continue Reading
Avèro Advisors Celebrates Continued Success and Growth Journey

Updated Category News Views 169

Avèro Advisors Celebrates Fifth Year on Inc. 5000 List Five years of consistent growth and innovation in client-focused public-sector transformation demonstrate Avèro Advisors' commitment to excellence. The technology and ERP consulting firm has once again earned a place on the prestigious Inc. 5000 list of America’s fastest-growing privately-held companies. This...

Continue Reading
Prospect Capital Boosts Preferred Stock Offering to $2.25 Billion

Updated Category News Views 83

Prospect Capital Expands Preferred Stock Offering In recent developments, Prospect Capital Corporation (NASDAQ: PSEC) has increased its preferred stock offering from $2 billion to $2.25 billion in aggregate liquidation preference, as detailed in a recent filing with the Securities and Exchange Commission (SEC). This amendment has been officially made through a new...

Continue Reading
MEXC Unveils SOON Token Listing with Exciting Rewards and Promotions

Updated Category News Views 268

MEXC Introduces SOON Token Listing In a significant move within the cryptocurrency landscape, MEXC, a prominent global cryptocurrency exchange, is excited to announce the listing of SOON ($SOON). This event will kick off with a vibrant expression of celebration, marking the arrival of SOON on the platform. The listings are scheduled to commence shortly, creating a ripple...

Continue Reading
Rosen Law Firm Investigates Electronic Arts Inc. for Securities Issues

Updated Category News Views 102

Rosen Law Firm Investigates Electronic Arts Inc. for Securities Concerns The Rosen Law Firm, a respected global firm dedicated to investors' rights, has launched an investigation into potential claims involving shareholders of Electronic Arts Inc. (NASDAQ: EA). The firm aims to bring attention to allegations suggesting that EA may have disseminated materially misleading...

Continue Reading